BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20887578)

  • 1. Combined effects of law enforcement and substitution treatment on heroin mortality.
    Nordt C; Stohler R
    Drug Alcohol Rev; 2010 Sep; 29(5):540-5. PubMed ID: 20887578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-threshold methadone treatment, heroin price, police activity and incidence of heroin use: the Zurich experience.
    Nordt C; Stohler R
    Int J Drug Policy; 2009 Nov; 20(6):497-501. PubMed ID: 19349154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Street-level drug law enforcement and entry into methadone maintenance treatment.
    Weatherburn D; Lind B
    Addiction; 2001 Apr; 96(4):577-87. PubMed ID: 11300961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of law enforcement activity on a heroin market.
    Weatherburn D; Lind B
    Addiction; 1997 May; 92(5):557-69; discussion 611-3. PubMed ID: 9219378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Law enforcement and drug treatment: a culture clash.
    Cohen J
    Science; 2010 Jul; 329(5988):169. PubMed ID: 20616266
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug supply and drug abuse.
    Copeman M
    CMAJ; 2003 Apr; 168(9):1113; author reply 1113. PubMed ID: 12719309
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid scale up of harm reduction in China.
    Sullivan SG; Wu Z
    Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value for money in drug treatment: economic evaluation of prison methadone.
    Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
    Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Canadian heroin supply coinciding with the Australian heroin shortage.
    Wood E; Stoltz JA; Li K; Montaner JS; Kerr T
    Addiction; 2006 May; 101(5):689-95. PubMed ID: 16669902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methadone maintenance: adoption of a new harm reduction approach in Hungary].
    Szabó L; Polgár P; Gerevich J
    Orv Hetil; 2005 Aug; 146(32):1685-91. PubMed ID: 16149246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug problems in Amsterdam.
    Scheele W
    Practitioner; 1989 Nov; 233(1478):1484-5. PubMed ID: 2616528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis and brain ischemic stroke in a heroin-dependent male. Invited comment.
    Somala RK
    Acta Psychiatr Scand; 2009 Jul; 120(1):80-1. PubMed ID: 19519677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Supervised injection. Under the watchful eye of nurses].
    Gagné L
    Perspect Infirm; 2013; 10(2):17-20. PubMed ID: 23539859
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological correlates of methadone maintenance pharmacotherapy.
    Kreek MJ
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():9-14. PubMed ID: 7880038
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality in heroin-assisted treatment in Switzerland 1994-2000.
    Rehm J; Frick U; Hartwig C; Gutzwiller F; Gschwend P; Uchtenhagen A
    Drug Alcohol Depend; 2005 Aug; 79(2):137-43. PubMed ID: 16002023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance treatment can be provided in a primary care setting without increasing methadone-related mortality: the Sheffield experience 1997-2000.
    Keen J; Oliver P; Mathers N
    Br J Gen Pract; 2002 May; 52(478):387-9. PubMed ID: 12014536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.